Cargando…
Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496588/ https://www.ncbi.nlm.nih.gov/pubmed/34118009 http://dx.doi.org/10.1007/s12026-021-09206-3 |
_version_ | 1784579783494991872 |
---|---|
author | Mahler, Michael Kim, Grace Roup, Fabrece Bentow, Chelsea Fabien, Nicole Goncalves, David Palterer, Boaz Fritzler, Marvin J. Villalta, Danilo |
author_facet | Mahler, Michael Kim, Grace Roup, Fabrece Bentow, Chelsea Fabien, Nicole Goncalves, David Palterer, Boaz Fritzler, Marvin J. Villalta, Danilo |
author_sort | Mahler, Michael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8496588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84965882021-10-19 Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies Mahler, Michael Kim, Grace Roup, Fabrece Bentow, Chelsea Fabien, Nicole Goncalves, David Palterer, Boaz Fritzler, Marvin J. Villalta, Danilo Immunol Res Correction Springer US 2021-06-12 2021 /pmc/articles/PMC8496588/ /pubmed/34118009 http://dx.doi.org/10.1007/s12026-021-09206-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Mahler, Michael Kim, Grace Roup, Fabrece Bentow, Chelsea Fabien, Nicole Goncalves, David Palterer, Boaz Fritzler, Marvin J. Villalta, Danilo Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title | Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title_full | Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title_fullStr | Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title_full_unstemmed | Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title_short | Correction to: Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
title_sort | correction to: evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496588/ https://www.ncbi.nlm.nih.gov/pubmed/34118009 http://dx.doi.org/10.1007/s12026-021-09206-3 |
work_keys_str_mv | AT mahlermichael correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT kimgrace correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT roupfabrece correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT bentowchelsea correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT fabiennicole correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT goncalvesdavid correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT paltererboaz correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT fritzlermarvinj correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies AT villaltadanilo correctiontoevaluationofanovelparticlebasedmultianalytetechnologyforthedetectionofantifibrillarinantibodies |